Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00601146 · ClinicalTrials.gov registry record · NA
Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT00601146 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 39 participants.
The verdict
NCT00601146, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
This research study is being done because patients with a history of chest radiation treatment for Hodgkin's disease have been shown to be at increased risk for developing lung cancer a number of years out from treatment. The risk appears to be further increased among patients with a smoking history. Currently, the practice is to recommend annual low-dose chest CT scans in survivors of Hodgkin's disease who have received prior chest radiation treatment and who have at least a moderate smoking history. In this study, the CT scans will be read and interpreted by the study radiologist, and the results recorded in a consistent manner.
Interventions
- PROCEDURE chest computed tomography scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2006-11-01 |
| Est. Completion | 2019-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00601146
The ClinicalTrials.gov registry entry for NCT00601146 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which chest computed tomography scan is the first listed.
NCT00601146 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00601146 about?
NCT00601146 is a clinical study titled "Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease". This research study is being done because patients with a history of chest radiation treatment for Hodgkin's disease have been shown to be at increased risk for developing lung cancer a number of years out from treatment. The risk appears to be further increased among patients with a smoking history...
What is the current status of trial NCT00601146?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2006-11-01. Estimated completion is 2019-12-01.
What interventions are being tested in trial NCT00601146?
The interventions under investigation include: chest computed tomography scan (PROCEDURE).
Who is sponsoring clinical trial NCT00601146?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.